Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
CA 2033249 C · Owner: Zeppezauer, Michael · Inventors: Zeppezauer, Michael; Leinenbach, Hans-Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
According to this invention the combination of active substances for use in therapeutic procedures consists of at least one cytostatic compound, e.g. vincristine methotrexate, cisplatin as the first agent and at least one histone and/or one active histone fragment with cytostatic or cytotoxic activity as the second agent. Both active agents act synergistically at the site of the pathogenic process.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 1990 and granted January 21, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 27, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.